Insulet (PODD) Profit After Tax (2010 - 2026)
Insulet's (PODD) quarterly Profit After Tax came in at $95.0 million in Q2 2026, up 322.22% on a YoY basis from $22.5 million in Q2 2025, and up 4.28% quarter-over-quarter from $91.1 million in Q1 2026.
Analysis
Insulet (PODD) Profit After Tax (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Profit After Tax for 17 consecutive years, with $95.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Profit After Tax rose 322.22% year-over-year to $95.0 million; the trailing twelve-month figure through Jun 2026 stood at $375.3 million (up 58.96% YoY), and the FY2025 full-year result was $247.1 million, down 40.93% from the prior year.
- Profit After Tax rose to $95.0 million in Q2 2026 per PODD's latest filing, from $91.1 million in the prior quarter.
- Across five years, Profit After Tax topped out at $188.6 million in Q2 2024 and bottomed at -$35.0 million in Q2 2022.
- Historically, Profit After Tax has averaged $59.0 million across 5 years, with a median of $51.7 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Profit After Tax sank 141.27% in 2022, then soared 1098.08% in 2023.
- Over 5 years, Profit After Tax stood at $17.0 million in 2022, then soared by 507.65% to $103.3 million in 2023, then decreased by 2.52% to $100.7 million in 2024, then grew by 0.89% to $101.6 million in 2025, then decreased by 6.5% to $95.0 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered $95.0 million, $91.1 million, and $101.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.69 Bn | 175.09 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 127.23 Bn | 122.02 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 116.90 Bn | 108.08 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 103.91 Bn | 100.43 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.54 Bn | 63.00 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 241.90 Mn |
| 7 | Alcon | 32.96 Bn | 31.51 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Insulet | 9.33 Bn | 8.79 Bn | 562.60 Mn | 95.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.00 Mn |
| Mar 31, 2026 | 91.10 Mn |
| Dec 31, 2025 | 101.60 Mn |
| Sep 30, 2025 | 87.60 Mn |
| Jun 30, 2025 | 22.50 Mn |
| Mar 31, 2025 | 35.40 Mn |
| Dec 31, 2024 | 100.70 Mn |
| Sep 30, 2024 | 77.50 Mn |
| Jun 30, 2024 | 188.60 Mn |
| Mar 31, 2024 | 51.50 Mn |
| Dec 31, 2023 | 103.30 Mn |
| Sep 30, 2023 | 51.90 Mn |
| Jun 30, 2023 | 27.30 Mn |
| Mar 31, 2023 | 23.80 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | -5.20 Mn |
| Jun 30, 2022 | -35.00 Mn |
| Mar 31, 2022 | 27.80 Mn |
| Dec 31, 2021 | 29.20 Mn |
| Sep 30, 2021 | 12.60 Mn |